Day: December 2, 2019

MATTOON, Ill., Dec. 02, 2019 (GLOBE NEWSWIRE) — Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) announced Bob Udell, president and chief executive officer of Consolidated Communications, will present at the Wells Fargo TMT Summit in Las Vegas on Wednesday, Dec. 4 at 3:20 p.m. PT.  The event will be webcast live and available on-demand on the Investor Relations section of the Consolidated Communications website.                                                                                                                                               About Consolidated Communications Consolidated Communications Holdings, Inc. (NASDAQ: CNSL) is a leading broadband and business communications provider serving consumers, businesses, and wireless and wireline carriers across rural and metro communities and a 23-state service...

La présentation détaillée transaction par transaction est disponible via le lien suivant : https://www.guerbet.com/media/f1jlhfcg/cp-rachat-actions-hebdomadaire-détaillée-02122019.pdfPionnier dans le domaine des produits de contraste avec plus de 90 années d’expérience, Guerbet est un des leaders de l’imagerie médicale au niveau mondial. Il dispose d’une gamme complète de produits pharmaceutiques, de dispositifs médicaux et de services pour l’imagerie diagnostique et interventionnelle afin d’améliorer la prise en charge thérapeutique des patients. Avec 8 % de ses ventes consacrées à la R&D et plus de 200 collaborateurs répartis dans 4 centres en France, en Israël et aux États-Unis, Guerbet mobilise d’importantes ressources pour la recherche et l’innovation. Guerbet (GBT) est coté au compartiment B d’Euronext Paris et a réalisé en 2018...

SINGAPORE, Dec. 02, 2019 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has commenced an underwritten public offering of its American Depositary Shares (“ADSs”) representing ordinary shares. In addition, ASLAN expects to grant the underwriter an option, exercisable at any time through and until one day before the potential closing date of this offering, to purchase up to an additional 15% of the ADSs being offered on the same terms and conditions. All ADSs to be sold in the offering will be offered by ASLAN. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.ASLAN intends to use the net proceeds...

Press releaseParis (France) – December 2, 2019, 6:15 pmYmagis S.A announces unanimous financial restructuring agreement with its bondholders and bank creditorsFinancial debt write-off of between €13.9m and €16.2mIssuance of €9.2m of convertible bonds based on ordinary shares with an implied price of €3.00 per ordinary shareRescheduling of €26.8m of residual debt over seven yearsYmagis presents its strategic plan and details of its financial restructuring plan in an appendix on its website www.ymagis.comYmagis Group (FR0011471291, MAGIS, PEA-PME), the European specialist in digital technologies for the cinema industry, today announced that an agreement has been reached with all its bondholders and bank creditors for a financial restructuring plan (the “Restructuring Agreement”) that meets the three objectives set by the Company during...

Communiqué de presseParis (France) – Le 2 décembre 2019 à 18h15Ymagis S.A. annonce avoir conclu un accord de restructuration financière à l’unanimité de ses créanciers obligataires et bancairesAbandon de la dette financière compris entre 13,9M€ et 16,2M€Émission de 9,2M€ d’obligations remboursables en actions ordinaires à un prix implicite de 3,00€ par action ordinaireRééchelonnement sur 7 ans de 26,8M€ de dette résiduelleYmagis présente en annexe et sur le site www.ymagis.com, son plan stratégique ainsi que le détail de son plan de restructuration financière.Réduire le montant total de la dette financière nette du groupe ;Renforcer les fonds propres de la société et du groupe ;Rééchelonner les échéances de la dette résiduelle.L’Accord de Restructuration a été approuvé à l’unanimité par ses prêteurs obligataires et bancaires.Évolution...

CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL ALPES PROVENCE                                                                                             Société coopérative à capital variable25, Chemin des trois cyprès 13097 Aix en Provence Cedex 2381 976 448 R.C.S Aix en ProvenceAix-en-Provence, le 2 décembre 2019Achats effectués dans les conditions de l’article 5 du règlement abus de marché dans le cadre du programme de rachat des Certificats Coopératifs d’Investissement autorisé par l’Assemblée Générale Mixte des sociétaires du 02 avril 2019.                                                                                             Le détail des transactions est disponible en annexe.Le Crédit Agricole Alpes Provence vous informe que le document est disponible sur son site Internet : http://www.ca-alpesprovence.fr et a été transmis...

Vancouver, B.C., Dec. 02, 2019 (GLOBE NEWSWIRE) — INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that Trevor Dixon is returning to the Board of Directors of the Company, his health issues having been resolved, effective today.  Mr. Dixon thanks Brenda Dixon for being his alternate Director while he was on medical leave.   Ms. Dixon continues her position as a Director and Quality Assurance Person of Acreage Pharms Ltd., a wholly owned subsidiary of the Company.For more information, please visit www.invictus-md.com.Marc RipaInterim Chief Executive OfficerInvestor Relations 1-844-800-6086E-Mail: connect@invictus-md.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange)...

Planned Phase 2 Studies in Ulcerative Colitis and Sjögren’s Syndrome to Start in 2020

LYON, France, Dec. 02, 2019 (GLOBE NEWSWIRE) —Listing markets:Euronext Paris from Euronext (Market segment C –  ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com        (1)  Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.(2)  Without treasury shares.PDF available at: http://ml.globenewswire.com/Resource/Download/36b6b78d-4725-4c4b-a4f2-7ec40ff69dbf